Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Fierce Pharma
Novartis investor calls for board overhaul after costly setbacks
A top-20 Novartis investor urged Chairman Giovanni Caforio to increase the board's scrutiny of deals.
Angus Liu
Sep 10, 2026 10:26am
Fortrea boosts early-phase platform with $45M acquisition
Sep 2, 2026 3:06pm
Skye and Redx combine with $125M to advance fibrosis assets
Aug 14, 2026 2:05pm
Jazz pays $820M to add epilepsy-focused Actio to its orchestra
Aug 10, 2026 10:40am
KKR inks $5.7B deal to take medtech manufacturer Integer private
Aug 4, 2026 9:09am
Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal
Jul 21, 2026 1:26pm
